High Levels of Fish Oil May Boost Risk for Prostate CancerHigh Levels of Fish Oil May Boost Risk for Prostate Cancer
High serum levels of long-chain omega-3 polyunsaturated fatty acids were associated with an increased risk, especially for high-grade disease. Medscape Medical News
Contributors : Chaima Cherif ; Julien Vernerey ; Nadine Carbuccia ; Palma Rocchi ; Estelle DuprezSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensMenin protein is encoded by the multiple endocrine neoplasia type 1 (MEN1) gene. It remains an enigmatic protein, known as a tumor suppressor but its roles in cancer development have attracted significant attention in recent years. The goals of this study is to understand how the Menin tumor suppressor can be oncogenic in Prostate, we have profiled Menin chromatin occupancy by chromatin immunoprecipitation coupled to high-throug...
British Journal of Cancer, Published online: 18 June 2019; doi:10.1038/s41416-019-0496-4Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
Condition: Prostate Cancer Metastatic Interventions: Procedure: Radical prostatectomy plus standard care; Drug: Standard of care for metastatic prostate cancer Sponsors: Fudan University; University College, London Recruiting
Condition: Healthy Volunteers Interventions: Other: Decision aid with implicit values clarification method (booklet or website); Other: Decision aid with explicit values clarification method (booklet or website) Sponsors: Universidade do Porto; NOVA Medical School; Georgetown University Not yet recruiting
Conditions: Stage I Prostate Cancer AJCC v8; Stage II Prostate Cancer AJCC v8; Stage IIA Prostate Cancer AJCC v8; Stage IIB Prostate Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8 Interventions: &...
A couple of years ago a team of U.S. and U.K. scientists came up with a way of making molecular motors that can drill through cancer cells, destroying them in the process. The researchers, from Rice University, Durham University, and North Carolina S...
CONCLUSIONS The present results suggest that targeting of PLCε/BMP-6/SMAD signaling may increase the sensitivity of CRPC to AR antagonists and inhibit tumor progression. PMID: 31201297 [PubMed - in process]
An analysis of the ARAMIS trial looked at quality of life and other outcomes with darolutamide in men with nonmetastatic castration-resistant prostate cancer.
You are leaving AARP.org and going to the website of our trusted provider. ... The provider ’s terms, conditions and policies apply. ... Please return to AARP.org to learn more about other benefits.
ConclusionOur study does not support reduced cancer mortality among anticoagulant users. Future studies on drug use and cancer mortality should be adjusted for anticoagulants as they are associated with significantly higher risk of cancer death.